Alison Schram, MD
Gynecologic Medical Oncologist & Early Drug Development Specialist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Early-Phase Clinical Trials
- Uterine (Endometrial) Cancer
- Ovarian Cancer
About Me
- Assistant Attending Physician
I am a medical oncologist with an expertise in early-phase clinical trials. I also care for women with uterine (endometrial) cancer, ovarian cancer, and cervical cancer.
Read more
My research focuses on finding and targeting the molecular changes that drive a person’s tumor. This allows us to more precisely tailor treatments to their disease. By developing and running early-phase clinical trials, I hope to bring new and more effective therapies to people with all types of cancer.
I understand that being diagnosed with cancer is scary, and navigating treatment can be overwhelming. I help guide my patients through the process so that they feel supported and confident in their care. Together, we create a personalized treatment plan based on what is important to them. I work with my colleagues in surgery, radiation oncology, supportive care, pathology, and radiology to find the best treatment approach for each person.
A gynecologic (GY-neh-kuh-LAH-jik) medical oncologist is a cancer doctor who specializes in gynecologic cancers. This includes cervical, fallopian tube, ovarian, uterine (endometrial), vaginal, and vulvar cancers.
An early drug development specialist tests new drugs to treat cancer. They have special training in research studies, known as clinical trials.
My Specialties
- Early-Phase Clinical Trials
- Uterine (Endometrial) Cancer
- Ovarian Cancer
- Cervical Cancer
Education
- MD, University of Pennsylvania
Residencies
- Internal Medicine - Brigham and Women’s Hospital
Fellowships
- Medical Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Schram sees patients at two locations.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Schram
- A Phase I Study of BGB-3245 in Patients with Metastatic Solid Tumors that Continue to Grow Despite Treatment
- A Phase I Study of RLY-2608 Alone in People with Solid Tumors or in Combination with Fulvestrant in People with Breast Cancer
- A Phase I Study of RP-6306 to Treat Advanced Solid Tumors with Certain Genetic Changes
- A Phase I/II Study of MCLA-128 in People with Advanced Solid Tumors with NRG1 Gene Fusions
Read more
- A Phase I/II Study of PC14586 in People with Solid Tumors Containing a p53 Y220C Mutation
- Clinical Trials Co-Investigated by Dr. Schram
- A Phase 1 Study of ETX-19477 in People With Advanced Solid Tumors
- A Phase 1 Study of RP-1664 in People With Advanced Solid Tumors With Certain Genetic Changes
- A Phase 1 Study of RP-3467 Alone and With Olaparib in People With Solid Tumors Having Certain Genetic Changes
- A Phase 1/2 Study of MRT-2359 in People with Advanced Lung Cancer and Other Solid Tumors
- A Phase 1/2 Study of VLS-1488 in People With Various Types of Cancer
- A Phase I/II Study of TPX-0005 in Patients with Advanced Solid Tumors
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Schram’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Alison Schram discloses the following relationships and financial interests:
-
Blueprint Medicines
Professional Services and Activities -
Flagship Pioneering
Professional Services and Activities -
Mersana Therapeutics
Professional Services and Activities -
Merus
Professional Services and Activities
-
PMV Pharma
Professional Services and Activities -
Relay Therapeutics, Inc.
Professional Services and Activities -
Repare Therapeutics
Professional Services and Activities -
Schrödinger, Inc.
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].